Annual EBIT
-$5.75 M
-$3.60 M-167.93%
31 December 2023
Summary:
ImmuCell annual earnings before interest & taxes is currently -$5.75 million, with the most recent change of -$3.60 million (-167.93%) on 31 December 2023. During the last 3 years, it has fallen by -$5.13 million (-827.70%). ICCC annual EBIT is now -367.71% below its all-time high of $2.70 million.ICCC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$567.00 K
+$820.90 K+59.15%
30 September 2024
Summary:
ImmuCell quarterly earnings before interest & taxes is currently -$567.00 thousand, with the most recent change of +$820.90 thousand (+59.15%) on 30 September 2024. Over the past year, it has increased by +$236.80 thousand (+29.46%). ICCC quarterly EBIT is now -161.11% below its all-time high of $927.90 thousand, reached on 31 March 2017.ICCC Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$3.22 M
+$236.80 K+6.85%
30 September 2024
Summary:
ImmuCell TTM earnings before interest & taxes is currently -$3.22 million, with the most recent change of +$236.80 thousand (+6.85%) on 30 September 2024. Over the past year, it has increased by +$2.67 million (+45.29%). ICCC TTM EBIT is now -249.91% below its all-time high of $2.15 million, reached on 31 December 2015.ICCC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICCC EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -167.9% | +29.5% | +45.3% |
| 3 y3 years | -827.7% | -342.0% | -993.1% |
| 5 y5 years | -301.3% | -46.1% | -108.7% |
ICCC EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -2521.2% | at low | -196.2% | +74.5% | -371.3% | +45.3% |
| 5 y | 5 years | -2521.2% | at low | -196.2% | +74.5% | -371.3% | +45.3% |
| alltime | all time | -367.7% | at low | -161.1% | +74.5% | -249.9% | +45.3% |
ImmuCell EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$567.00 K(-59.1%) | -$3.22 M(-6.9%) |
| June 2024 | - | -$1.39 M(+377.8%) | -$3.46 M(+2.9%) |
| Mar 2024 | - | -$290.50 K(-70.2%) | -$3.36 M(-36.5%) |
| Dec 2023 | -$5.75 M(+167.9%) | -$973.50 K(+21.1%) | -$5.29 M(-10.1%) |
| Sept 2023 | - | -$803.80 K(-37.7%) | -$5.88 M(+4.3%) |
| June 2023 | - | -$1.29 M(-42.0%) | -$5.64 M(+14.0%) |
| Mar 2023 | - | -$2.22 M(+41.9%) | -$4.95 M(+131.7%) |
| Dec 2022 | -$2.15 M(-1003.7%) | -$1.57 M(+178.0%) | -$2.14 M(+403.0%) |
| Sept 2022 | - | -$563.70 K(-5.2%) | -$424.60 K(-213.7%) |
| June 2022 | - | -$594.70 K(-200.9%) | $373.40 K(-68.5%) |
| Mar 2022 | - | $589.60 K(+308.9%) | $1.19 M(+408.2%) |
| Dec 2021 | $237.40 K(-138.3%) | $144.20 K(-38.5%) | $233.50 K(-35.2%) |
| Sept 2021 | - | $234.30 K(+7.2%) | $360.40 K(-398.3%) |
| June 2021 | - | $218.60 K(-160.1%) | -$120.80 K(-88.3%) |
| Mar 2021 | - | -$363.60 K(-234.1%) | -$1.03 M(+66.0%) |
| Dec 2020 | -$619.60 K(-25.8%) | $271.10 K(-209.8%) | -$619.50 K(-44.0%) |
| Sept 2020 | - | -$246.90 K(-64.1%) | -$1.11 M(-11.3%) |
| June 2020 | - | -$688.70 K(-1630.4%) | -$1.25 M(+17.9%) |
| Mar 2020 | - | $45.00 K(-120.9%) | -$1.06 M(+26.6%) |
| Dec 2019 | -$835.60 K(-41.7%) | -$215.30 K(-44.5%) | -$835.60 K(-45.8%) |
| Sept 2019 | - | -$388.10 K(-22.3%) | -$1.54 M(+18.6%) |
| June 2019 | - | -$499.80 K(-286.8%) | -$1.30 M(+31.3%) |
| Mar 2019 | - | $267.60 K(-129.0%) | -$990.40 K(-30.9%) |
| Dec 2018 | -$1.43 M(+551.3%) | -$921.80 K(+531.8%) | -$1.43 M(+55.4%) |
| Sept 2018 | - | -$145.90 K(-23.3%) | -$921.60 K(-26.5%) |
| June 2018 | - | -$190.30 K(+9.2%) | -$1.25 M(-5.1%) |
| Mar 2018 | - | -$174.30 K(-57.6%) | -$1.32 M(+501.2%) |
| Dec 2017 | -$219.90 K(-123.9%) | -$411.10 K(-14.1%) | -$219.90 K(-173.7%) |
| Sept 2017 | - | -$478.50 K(+85.3%) | $298.20 K(-64.6%) |
| June 2017 | - | -$258.20 K(-127.8%) | $842.10 K(-25.8%) |
| Mar 2017 | - | $927.90 K(+767.2%) | $1.14 M(+23.4%) |
| Dec 2016 | $920.00 K(-57.2%) | $107.00 K(+63.6%) | $920.00 K(-28.4%) |
| Sept 2016 | - | $65.40 K(+86.3%) | $1.29 M(-30.4%) |
| June 2016 | - | $35.10 K(-95.1%) | $1.85 M(-9.1%) |
| Mar 2016 | - | $712.50 K(+50.9%) | $2.03 M(-5.4%) |
| Dec 2015 | $2.15 M(-1186.6%) | $472.30 K(-24.6%) | $2.15 M(+14.4%) |
| Sept 2015 | - | $626.80 K(+184.4%) | $1.88 M(+45.0%) |
| June 2015 | - | $220.40 K(-73.4%) | $1.29 M(+110.8%) |
| Mar 2015 | - | $827.70 K(+309.5%) | $613.90 K(-410.5%) |
| Dec 2014 | -$197.60 K(-172.7%) | $202.10 K(+358.3%) | -$197.70 K(-68.9%) |
| Sept 2014 | - | $44.10 K(-109.6%) | -$636.50 K(+8.4%) |
| June 2014 | - | -$460.00 K(-2957.1%) | -$587.20 K(+487.8%) |
| Mar 2014 | - | $16.10 K(-106.8%) | -$99.90 K(-136.7%) |
| Dec 2013 | $271.90 K(+1.7%) | -$236.70 K(-353.4%) | $271.90 K(-47.3%) |
| Sept 2013 | - | $93.40 K(+242.1%) | $515.50 K(+48.8%) |
| June 2013 | - | $27.30 K(-93.0%) | $346.40 K(-5.1%) |
| Mar 2013 | - | $387.90 K(+5521.7%) | $365.10 K(+36.5%) |
| Dec 2012 | $267.40 K(-143.5%) | $6900.00(-109.1%) | $267.40 K(-5.5%) |
| Sept 2012 | - | -$75.70 K(-264.6%) | $283.10 K(+68.1%) |
| June 2012 | - | $46.00 K(-84.1%) | $168.40 K(-153.8%) |
| Mar 2012 | - | $290.20 K(+1184.1%) | -$313.30 K(-49.1%) |
| Dec 2011 | -$615.30 K(-7.0%) | $22.60 K(-111.9%) | -$615.00 K(-25.9%) |
| Sept 2011 | - | -$190.40 K(-56.3%) | -$829.80 K(-15.9%) |
| June 2011 | - | -$435.70 K(+3688.7%) | -$986.90 K(+64.8%) |
| Mar 2011 | - | -$11.50 K(-94.0%) | -$598.80 K(-8.2%) |
| Dec 2010 | -$661.80 K(+54.4%) | -$192.20 K(-44.7%) | -$652.10 K(+18.7%) |
| Sept 2010 | - | -$347.50 K(+630.0%) | -$549.40 K(+147.5%) |
| June 2010 | - | -$47.60 K(-26.5%) | -$222.00 K(-54.7%) |
| Mar 2010 | - | -$64.80 K(-27.6%) | -$490.20 K(-1.5%) |
| Dec 2009 | -$428.50 K(-63.3%) | -$89.50 K(+345.3%) | -$497.90 K(-28.9%) |
| Sept 2009 | - | -$20.10 K(-93.6%) | -$700.40 K(-43.1%) |
| June 2009 | - | -$315.80 K(+335.6%) | -$1.23 M(-6.0%) |
| Mar 2009 | - | -$72.50 K(-75.2%) | -$1.31 M(+12.1%) |
| Dec 2008 | -$1.17 M(-233.9%) | -$292.00 K(-46.9%) | -$1.17 M(+42.7%) |
| Sept 2008 | - | -$549.70 K(+39.2%) | -$818.30 K(-404.5%) |
| June 2008 | - | -$394.80 K(-672.2%) | $268.70 K(-47.4%) |
| Mar 2008 | - | $69.00 K(+20.6%) | $510.80 K(-41.4%) |
| Dec 2007 | $872.10 K(+13.2%) | $57.20 K(-89.4%) | $872.10 K(-7.5%) |
| Sept 2007 | - | $537.30 K(-451.9%) | $943.00 K(+51.3%) |
| June 2007 | - | -$152.70 K(-135.5%) | $623.30 K(-16.3%) |
| Mar 2007 | - | $430.30 K(+235.9%) | $744.30 K(-3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2006 | $770.70 K(-17.8%) | $128.10 K(-41.1%) | $770.60 K(-16.3%) |
| Sept 2006 | - | $217.60 K(-786.4%) | $920.30 K(+8.7%) |
| June 2006 | - | -$31.70 K(-106.9%) | $846.30 K(-13.8%) |
| Mar 2006 | - | $456.60 K(+64.4%) | $981.50 K(+4.6%) |
| Dec 2005 | $938.00 K(+676.5%) | $277.80 K(+93.5%) | $938.00 K(+48.5%) |
| Sept 2005 | - | $143.60 K(+38.7%) | $631.70 K(+35.0%) |
| June 2005 | - | $103.50 K(-74.9%) | $467.90 K(+83.9%) |
| Mar 2005 | - | $413.10 K(-1549.5%) | $254.50 K(+110.7%) |
| Dec 2004 | $120.80 K(-128.2%) | -$28.50 K(+41.1%) | $120.80 K(-283.9%) |
| Sept 2004 | - | -$20.20 K(-81.6%) | -$65.70 K(-43.1%) |
| June 2004 | - | -$109.90 K(-139.3%) | -$115.40 K(-47.4%) |
| Mar 2004 | - | $279.40 K(-230.0%) | -$219.50 K(-48.8%) |
| Dec 2003 | -$429.00 K(-180.5%) | -$215.00 K(+207.6%) | -$429.00 K(-1621.3%) |
| Sept 2003 | - | -$69.90 K(-67.3%) | $28.20 K(-78.5%) |
| June 2003 | - | -$214.00 K(-406.2%) | $131.40 K(-58.3%) |
| Mar 2003 | - | $69.90 K(-71.1%) | $314.90 K(-40.9%) |
| Dec 2002 | $533.10 K(-20.5%) | $242.20 K(+627.3%) | $533.20 K(-23.9%) |
| Sept 2002 | - | $33.30 K(-209.2%) | $700.70 K(+20.4%) |
| June 2002 | - | -$30.50 K(-110.6%) | $581.80 K(-25.5%) |
| Mar 2002 | - | $288.20 K(-29.7%) | $780.60 K(+16.4%) |
| Dec 2001 | $670.90 K(+62.3%) | $409.70 K(-578.6%) | $670.80 K(+21.5%) |
| Sept 2001 | - | -$85.60 K(-150.9%) | $551.90 K(+1.9%) |
| June 2001 | - | $168.30 K(-5.7%) | $541.80 K(+38.1%) |
| Mar 2001 | - | $178.40 K(-38.7%) | $392.30 K(-5.1%) |
| Dec 2000 | $413.40 K(-32.8%) | $290.80 K(-403.9%) | $413.30 K(+78.5%) |
| Sept 2000 | - | -$95.70 K(-609.0%) | $231.60 K(-52.4%) |
| June 2000 | - | $18.80 K(-90.6%) | $486.50 K(+4.0%) |
| Mar 2000 | - | $199.40 K(+82.8%) | $467.70 K(-17.7%) |
| Dec 1999 | $615.00 K(>+9900.0%) | $109.10 K(-31.5%) | $568.30 K(+23.8%) |
| Sept 1999 | - | $159.20 K(>+9900.0%) | $459.20 K(+53.1%) |
| June 1999 | - | $0.00(-100.0%) | $300.00 K(0.0%) |
| Mar 1999 | - | $300.00 K(>+9900.0%) | $300.00 K(+200.0%) |
| Dec 1998 | $0.00(-100.0%) | $0.00(0.0%) | $100.00 K(-78.1%) |
| Sept 1998 | - | $0.00(0.0%) | $456.70 K(+28.0%) |
| June 1998 | - | $0.00(-100.0%) | $356.70 K(+127.6%) |
| Mar 1998 | - | $100.00 K(-72.0%) | $156.70 K(-39.0%) |
| Dec 1997 | $256.70 K(-356.7%) | $356.70 K(-456.7%) | $256.70 K(-14.4%) |
| Sept 1997 | - | -$100.00 K(-50.0%) | $300.00 K(+50.0%) |
| June 1997 | - | -$200.00 K(-200.0%) | $200.00 K(0.0%) |
| Mar 1997 | - | $200.00 K(-50.0%) | $200.00 K(>+9900.0%) |
| Dec 1996 | -$100.00 K(<-9900.0%) | $400.00 K(-300.0%) | $0.00(-100.0%) |
| Sept 1996 | - | -$200.00 K(0.0%) | -$400.00 K(+33.3%) |
| June 1996 | - | -$200.00 K(<-9900.0%) | -$300.00 K(+50.0%) |
| Mar 1996 | - | $0.00(0.0%) | -$200.00 K(+100.0%) |
| Dec 1995 | $0.00(-100.0%) | $0.00(-100.0%) | -$100.00 K(-66.7%) |
| Sept 1995 | - | -$100.00 K(0.0%) | -$300.00 K(+50.0%) |
| June 1995 | - | -$100.00 K(-200.0%) | -$200.00 K(<-9900.0%) |
| Mar 1995 | - | $100.00 K(-150.0%) | $0.00(0.0%) |
| Dec 1994 | -$300.00 K(+200.0%) | -$200.00 K(<-9900.0%) | $0.00(-100.0%) |
| Sept 1994 | - | $0.00(-100.0%) | $100.00 K(0.0%) |
| June 1994 | - | $100.00 K(0.0%) | $100.00 K(>+9900.0%) |
| Mar 1994 | - | $100.00 K(-200.0%) | $0.00(-100.0%) |
| Dec 1993 | -$100.00 K(-66.7%) | -$100.00 K(<-9900.0%) | -$100.00 K(0.0%) |
| Sept 1993 | - | $0.00(0.0%) | -$100.00 K(-50.0%) |
| June 1993 | - | $0.00(0.0%) | -$200.00 K(+100.0%) |
| Mar 1993 | - | $0.00(-100.0%) | -$100.00 K(-50.0%) |
| Dec 1992 | -$300.00 K(-78.6%) | -$100.00 K(0.0%) | -$200.00 K(-33.3%) |
| Sept 1992 | - | -$100.00 K(-200.0%) | -$300.00 K(-57.1%) |
| June 1992 | - | $100.00 K(-200.0%) | -$700.00 K(-36.4%) |
| Mar 1992 | - | -$100.00 K(-50.0%) | -$1.10 M(-26.7%) |
| Dec 1991 | -$1.40 M(+180.0%) | -$200.00 K(-60.0%) | -$1.50 M(+36.4%) |
| Sept 1991 | - | -$500.00 K(+66.7%) | -$1.10 M(+22.2%) |
| June 1991 | - | -$300.00 K(-40.0%) | -$900.00 K(+28.6%) |
| Mar 1991 | - | -$500.00 K(-350.0%) | -$700.00 K(+40.0%) |
| Dec 1990 | -$500.00 K(-44.4%) | $200.00 K(-166.7%) | -$500.00 K(-44.4%) |
| Sept 1990 | - | -$300.00 K(+200.0%) | -$900.00 K(+50.0%) |
| June 1990 | - | -$100.00 K(-66.7%) | -$600.00 K(-45.5%) |
| Mar 1990 | - | -$300.00 K(+50.0%) | -$1.10 M(+1000.0%) |
| Dec 1989 | -$900.00 K | -$200.00 K(<-9900.0%) | -$100.00 K(-200.0%) |
| Sept 1989 | - | $0.00(-100.0%) | $100.00 K(0.0%) |
| June 1989 | - | -$600.00 K(-185.7%) | $100.00 K(-85.7%) |
| Mar 1989 | - | $700.00 K | $700.00 K |
FAQ
- What is ImmuCell annual earnings before interest & taxes?
- What is the all time high annual EBIT for ImmuCell?
- What is ImmuCell annual EBIT year-on-year change?
- What is ImmuCell quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ImmuCell?
- What is ImmuCell quarterly EBIT year-on-year change?
- What is ImmuCell TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ImmuCell?
- What is ImmuCell TTM EBIT year-on-year change?
What is ImmuCell annual earnings before interest & taxes?
The current annual EBIT of ICCC is -$5.75 M
What is the all time high annual EBIT for ImmuCell?
ImmuCell all-time high annual earnings before interest & taxes is $2.70 M
What is ImmuCell annual EBIT year-on-year change?
Over the past year, ICCC annual earnings before interest & taxes has changed by -$3.60 M (-167.93%)
What is ImmuCell quarterly earnings before interest & taxes?
The current quarterly EBIT of ICCC is -$567.00 K
What is the all time high quarterly EBIT for ImmuCell?
ImmuCell all-time high quarterly earnings before interest & taxes is $927.90 K
What is ImmuCell quarterly EBIT year-on-year change?
Over the past year, ICCC quarterly earnings before interest & taxes has changed by +$236.80 K (+29.46%)
What is ImmuCell TTM earnings before interest & taxes?
The current TTM EBIT of ICCC is -$3.22 M
What is the all time high TTM EBIT for ImmuCell?
ImmuCell all-time high TTM earnings before interest & taxes is $2.15 M
What is ImmuCell TTM EBIT year-on-year change?
Over the past year, ICCC TTM earnings before interest & taxes has changed by +$2.67 M (+45.29%)